[Problems on cortison therapy of obstructive pulmonary diseases (author's transl)].
The use of cortison derivates is connected with some problems also in therapy of obstructive pulmonary diseases. Considering the multiplicity of new preparations and the variability of their application it is necessary to give this drugs under control depending individually on the stage of the disease. The present knowledge of pharmacodynamic actions of cortison therapy is mentioned. Refering to 30 own cases it is confirmed that depot cortison derivates have not fulfilled the expectations.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000403:Airway Resistance; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D003348:Cortisone / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008176:Lung Volume Measurements; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000032:analysis; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
D003692:Delayed-Action Preparations; D014222:Triamcinolone Acetonide; D010100:Oxygen; D003348:Cortisone
Zur Problematik der Kortikoidtherapie bei obstruktiven Lungenkrankheiten.